AI assistant
Sun Pharma Advanced Research Company Ltd. — Proxy Solicitation & Information Statement 2021
May 26, 2021
60740_rns_2021-05-26_17aff797-5694-4e89-8fca-eab707da22c1.pdf
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
SPARC/Sec/SE/2021-22/018
26[th] May 2021
National Stock Exchange of India Ltd, Exchange Plaza, 5th Floor, Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051.
BSE Limited., Market Operations Dept. P. J. Towers, Dalal Street, Mumbai - 400 001.
Dear Sir/ Madam,
- Subject: Corrigendum to Notice of the Extra ordinary General Meeting of the Company on Tuesday, 8[th] June 2021 at 04.00 p.m.
Reference: Our letter dated 17[th] May 2021 under reference No. SPARC/Sec/SE/2021-22/016 with subject ‘Notice of the Extra-ordinary General Meeting of the Company. ’
With reference to the Notice convening Extra-Ordinary General Meeting of the Company on Tuesday, 8[th] June 2021 at 04.00 p.m. IST, through Video Conferencing (“VC”)/ Other Audio Visual Means (“OAVM”), (‘EGM Notice’ ) the Company has issued a ‘clarificatory’ Corrigendum to the shareholders, which is enclosed herewith for your record & dissemination.
Please note that the Corrigendum is being issued as a measure of abundant precaution with limited intent to clarify on disclosures relating to ultimate beneficial owners made in the table of para 6 of the explanatory statement of the EGM Notice.
This communication should be read along with the original EGM Notice dated 12[th] May 2021 which was submitted to the Exchange along with the above mentioned letter.
The EGM Notice along with the Corrigendum is also available on the website of the Company and can be accessed using the link: https://www.sparc.life/announcements-disclosures
Inconvenience caused in this regard is deeply regretted.
You are requested to kindly take the same on record.
Yours faithfully,
For Sun Pharma Advanced Research Company Ltd.,
==> picture [103 x 48] intentionally omitted <==
Debashis Dey
Company Secretary
Encls: A/a
==> picture [595 x 109] intentionally omitted <==
==> picture [81 x 36] intentionally omitted <==
SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
Registered Office : Plot No. 5 & 6/1, Savli G.I.D.C. Estate, Savli - Vadodara Highway, Manjusar, Vadodara - 391775, Gujarat, India. CIN: L73100GJ2006PLC047837 Website: www.sparc.life
CORRIGENDUM TO EGM NOTICE
The Notice of Extra-ordinary General Meeting dated May 12, 2021 (“ EGM Notice ”) shall be read with this corrigendum (“ Corrigendum ”).
This Corrigendum is issued as a measure of abundant precaution, with limited intent to clarify on disclosures relating to ultimate beneficial owners made in the table of para 6 of the Explanatory Statement of the EGM Notice.
- In the table under point 6 of the Explanatory Statement of the EGM Notice, the particulars of investors at Sr. Nos. 8, 20 and 34 shall be updated with the particulars of Ultimate Beneficial Owners and shall be read as follows:
| Sr. No. |
Name of the Proposed Allottees |
Ultimate Beneficial Owners (If applicable) |
Pre Issue Equity holding |
Pre Issue Equity holding |
No. of warrants to be allotted |
Post issue Equity holding (After exercise of Warrants) 1 |
Post issue Equity holding (After exercise of Warrants) 1 |
|---|---|---|---|---|---|---|---|
| No. of shares |
% | No. of shares |
% | ||||
| 8 | Abakkus Growth Fund – 1 |
1. Sunil Singhania5 2. Biharilal Deora5 |
NIL | NA | 14,04,494 | 14,04,494 | 0.43% |
| 20 | The Ram Fund, L.P. |
1. William I. Lee5 2. NancyC. Evertt5 |
NIL | NA | 4,74,269 | 4,74,269 | 0.14% |
| 34 | TIFF Global Equity Fund, L.P. |
Richard J. Flannery5 | NIL | NA | 62,808 | 62,808 | 0.02% |
-
The Notes under the table (under para 6 of the Explanatory Statement) shall be updated and read as follows:
-
Note[3] shall be updated and read as follows:
3 Allottee is a FPI - Category 1 registered with SEBI.
- After existing Note[4] , the following notes shall be added as Note[5] 5 Name of Senior managing Official(s)/Designated Partner(s )( since Allotee is a FPI – Category 2/ AIF registered with SEBI, with no single natural person’s stake being more than the threshold limit)
By order of the Board of Directors For Sun Pharma Advanced Research Company Limited
Debashis Dey Company Secretary
Place: Mumbai Date: May 25, 2021
Page 1 of 1